feed,title,long_url,short_url
Benzinga,Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M,https://benzinga.com/general/biotech/24/05/38878697/johnson-johnson-to-acquire-early-stage-eczema-treatment-developer-proteologix-for-850m,https://da.gd/bdV5V
